中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2015年
16期
112-113
,共2页
孟鲁司特%不同病原感染%毛细支气管炎
孟魯司特%不同病原感染%毛細支氣管炎
맹로사특%불동병원감염%모세지기관염
Montelukast%Different pathogen infection%Bronchiolitis
目的:探讨孟鲁司特治疗不同病原感染后毛细支气管炎的疗效。方法该研究随机选取该院于2013年1月-2014年10月收治的100例不同病原感染后毛细支气管炎患者,将其分为腺病毒组和副流感病毒组,两组患者都采用孟鲁司特治疗方式,对比两组患者的病原性检测结果、住院时间、临床症状评分结果、临床疗效以及不良反应发生率结果。结果腺病毒组患者的住院时间、临床症状(咳嗽、哮鸣音以及喘息)评分结果分别是(7.42±2.34)d、(0.96±0.38)分、(0.76±0.98)分和(1.12±1.20)分,副流感病毒组患者的住院时间、临床症状(咳嗽、哮鸣音以及喘息)评分结果分别是(7.76±2.38)d、(1.01±0.45)分、(0.79±0.77)分和(1.14±1.17)分,两组结果对比差异无统计学意义(P>0.05)。结论采用孟鲁司特治疗不同病原感染后毛细支气管炎患者有很好的临床效果,尤其是对于副流感病毒感染引起的支气管炎患者有着显著疗效,能够有效的降低患者的不良反应发生率,使得患者早日出院,值得在临床上推广应用。
目的:探討孟魯司特治療不同病原感染後毛細支氣管炎的療效。方法該研究隨機選取該院于2013年1月-2014年10月收治的100例不同病原感染後毛細支氣管炎患者,將其分為腺病毒組和副流感病毒組,兩組患者都採用孟魯司特治療方式,對比兩組患者的病原性檢測結果、住院時間、臨床癥狀評分結果、臨床療效以及不良反應髮生率結果。結果腺病毒組患者的住院時間、臨床癥狀(咳嗽、哮鳴音以及喘息)評分結果分彆是(7.42±2.34)d、(0.96±0.38)分、(0.76±0.98)分和(1.12±1.20)分,副流感病毒組患者的住院時間、臨床癥狀(咳嗽、哮鳴音以及喘息)評分結果分彆是(7.76±2.38)d、(1.01±0.45)分、(0.79±0.77)分和(1.14±1.17)分,兩組結果對比差異無統計學意義(P>0.05)。結論採用孟魯司特治療不同病原感染後毛細支氣管炎患者有很好的臨床效果,尤其是對于副流感病毒感染引起的支氣管炎患者有著顯著療效,能夠有效的降低患者的不良反應髮生率,使得患者早日齣院,值得在臨床上推廣應用。
목적:탐토맹로사특치료불동병원감염후모세지기관염적료효。방법해연구수궤선취해원우2013년1월-2014년10월수치적100례불동병원감염후모세지기관염환자,장기분위선병독조화부류감병독조,량조환자도채용맹로사특치료방식,대비량조환자적병원성검측결과、주원시간、림상증상평분결과、림상료효이급불량반응발생솔결과。결과선병독조환자적주원시간、림상증상(해수、효명음이급천식)평분결과분별시(7.42±2.34)d、(0.96±0.38)분、(0.76±0.98)분화(1.12±1.20)분,부류감병독조환자적주원시간、림상증상(해수、효명음이급천식)평분결과분별시(7.76±2.38)d、(1.01±0.45)분、(0.79±0.77)분화(1.14±1.17)분,량조결과대비차이무통계학의의(P>0.05)。결론채용맹로사특치료불동병원감염후모세지기관염환자유흔호적림상효과,우기시대우부류감병독감염인기적지기관염환자유착현저료효,능구유효적강저환자적불량반응발생솔,사득환자조일출원,치득재림상상추엄응용。
Objective To investigate the effect of montelukast treatment on bronchiolitis induced by different etiological agents. Methods This paper selected 100 patients with bronchiolitis induced by different etiological agents treated in our hospital between January 2013 and October 2014 as the research object and divided them into the adenovirus group and parainfluenza virus group. All of them received montelukast treatment. Pathogenic detection results, hospitalization time, symptom score results, clinical cura-tive effect and adverse reaction were compared between the two groups. Results The adenovirus group patients hospitalization time, clinical symptoms (cough, wheezing andwheezing) score results are (7.42±2.34) days, (0.96±0.38), (0.76±0.98) and (1.12±1.20), parainfluenza virus group patients hospitalization time, clinical symptoms shape (cough, wheezing and wheezing) score results are (7.76±2.38) days, (1.01±0.45), (0.79±0.77) and (1.14±1.17), the two sets of results compared no significant difference (P>0.05), has no statistical significance. Conclusion The use of montelukast in the treatment of differentpathogen infection bronchiolitis patients had good clinical effects, especially the causes for parainfluenza virusinfection bronchitis patients with obvious curative effect, can effectively reduce the incidence of adverse reaction of patients, making patients for early discharge, worth in clinical application.